Preliminary results on anal cancer by applying intensity modulated radiotherapy and synchronous capecitabine chemotherapy simultaneously

BACKGROUND: Anal cancer is a rare clinical disease with the incidence rate of 1–2/10 million. The present study aims to assess the feasibility, safety and short-term outcome of the simultaneous integrated boost intensity-modulated radiotherapy (SIB-IMRT) schedule with oral capecitabine in patients w...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Wei-Dong, Jiang, Hua-Yong, Gao, Jun-Mao, Du, Jun-Feng, Chen, Gang, Zhang, Fu-Li
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8798329/
https://www.ncbi.nlm.nih.gov/pubmed/35117802
http://dx.doi.org/10.21037/tcr-19-2843

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8798329/
https://www.ncbi.nlm.nih.gov/pubmed/35117802
http://dx.doi.org/10.21037/tcr-19-2843

Ejemplares similares